December 12, 2022

Symbicort budesonide/formoterol Patent expiration date:

  • January 29, 2023 A generic version of Symbicort has been approved by the FDA. The following products are equivalent to Symbicort and have been approved by the FDA:
  • For the treatment of asthma in patients 6 years of age and older
  • For reducing exacerbations of chronic obstructive pulmonary disease
  • For maintenance treatment of chronic obstructive pulmonary disease Breyna Generic name: budesonide and formoterol fumarate Dosage form: aerosol, metered.
  • Read more…

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail Clients: Contact your Client Relations Manager